Review article: the aetiology of primary Budd–Chiari syndrome – differences between the West and China

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Alimentary Pharmacology and Therapeutics

• Publication date

  2016-12-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1111/apt.13815PMID 27734511
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The impact of MTHFR 677 C/T genotypes on folate status markers: a meta-analysis of folic acid intervention studies

  2017cited by this paper
• CALR mutations in Chinese Budd-Chiari syndrome patients.

  2016cited by this paper
• EASL Clinical Practice Guidelines on the prevention, diagnosis and treatment of gallstones.

  2016cited by this paper
• Liver

  2016cited by this paper
• EASL Clinical Practice Guidelines: Vascular diseases of the liver.

  2016cited by this paper
• Circulating microRNA profile in patients with membranous obstruction of the inferior vena cava

  2016cited by this paper
• Comparison of Long-Term Outcomes of Endovascular Management for Membranous and Segmental Inferior Vena Cava Obstruction in Patients With Primary Budd–Chiari Syndrome

  2016cited by this paper
• Long‐term safety and outcome of percutaneous transhepatic venous balloon angioplasty for Budd–Chiari syndrome

  2016cited by this paper
• Leg Ulcer in Budd-Chiari syndrome

  2016cited by this paper
• Role of calreticulin mutations in the aetiological diagnosis of splanchnic vein thrombosis.

  2015cited by this paper
• Percutaneous recanalization for combined-type Budd–Chiari syndrome: strategy and long-term outcome

  2015cited by this paper
• Incidence of CALR mutations in patients with splanchnic vein thrombosis

  2015cited by this paper
• Difference in Budd‐Chiari syndrome between the west and china

  2015cited by this paper
• Incidence of venous thromboembolism during pregnancy and the puerperium: a systematic review and meta-analysis

  2015cited by this paper
• Prevalence of Budd-Chiari Syndrome during Pregnancy or Puerperium: A Systematic Review and Meta-Analysis

  2015influential reference
• Recurrent Budd-Chiari Syndrome Presenting with Lower Limb Ulcers.

  2015cited by this paper
• P1288 : Budd chiari syndrome (BCS) in France from a large national cohort

  2015influential reference
• Difference in Budd-Chiari Syndrome Between the West and China

  2015cited by this paper
• Detection of the CALR mutation in the diagnosis of splanchnic vein thrombosis

  2015cited by this paper
• CALR mutations screening should not be studied in splanchnic vein thrombosis

  2015cited by this paper
• Splanchnic vein thrombosis and myeloproliferative neoplasms: molecular-driven diagnosis and long-term treatment

  2015cited by this paper
• Somatic calreticulin mutations in patients with Budd-Chiari syndrome and portal vein thrombosis

  2015cited by this paper
• Budd-Chiari Syndrome in China: A Systematic Analysis of Epidemiological Features Based on the Chinese Literature Survey

  2015influential reference
• Serum Iodine Is Increased in Subjects Having Budd–Chiari Syndrome

  2015cited by this paper
• Associations of Antiphospholipid Antibodies With Splanchnic Vein Thrombosis

  2015influential reference
• Prevalence of hyperhomocysteinaemia and some of its major determinants in Shaanxi Province, China: a cross-sectional study

  2015cited by this paper
• Paroxysmal Nocturnal Hemoglobinuria is rare cause for thrombosis of the intra‐abdominal veins in the ethnic Indian population – results from FLAER‐based flowcytometry screening

  2014cited by this paper
• Budd-Chiari syndrome: a single-center experience.

  2014cited by this paper
• Acute Budd–Chiari syndrome due to a simple liver cyst

  2014cited by this paper
• Associations of coagulation factor V Leiden and prothrombin G20210A mutations with Budd-Chiari syndrome and portal vein thrombosis: a systematic review and meta-analysis.

  2014cited by this paper
• Methylenetetrahydrofolate reductase C677T gene mutation and hyperhomocysteinemia in Budd–Chiari syndrome and portal vein thrombosis: A systematic review and meta‐analysis of observational studies

  2014cited by this paper
• Images in clinical medicine. Abdominal-wall varices in the Budd-Chiari syndrome.

  2014cited by this paper
• Initial Imaging Analysis of Budd-Chiari Syndrome in Henan Province of China: Most Cases Have Combined Inferior Vena Cava and Hepatic Veins Involvement

  2014cited by this paper
• Good clinical outcomes following transjugular intrahepatic portosystemic stent‐shunts in Budd–Chiari syndrome

  2014cited by this paper
• Transjugular intrahepatic portosystemic shunt for Budd–Chiari syndrome: techniques, indications and results on 51 Chinese patients from a single centre

  2014cited by this paper
• JAK2 V617F mutation and 46/1 haplotype in Chinese Budd‐Chiari syndrome patients

  2014cited by this paper
• Scientific publications on portal vein thrombosis and Budd-Chiari syndrome: a global survey of the literature.

  2014cited by this paper
• Selection of treatment modalities for Budd-Chiari Syndrome in China: a preliminary survey of published literature.

  2014cited by this paper
• Budd-Chiari syndrome secondary to inflammatory pseudotumor of the liver: Report of a case with a 10-year follow-up.

  2013cited by this paper
• Prevalence of covert duplicate publications in Budd-Chiari syndrome articles in China: a systematic analysis.

  2013influential reference
• Síndrome de Budd-Chiari secundario a pseudotumor inflamatorio hepático: seguimiento durante 10 años

  2013cited by this paper
• Prevalence of paroxysmal nocturnal hemoglobinuria in Chinese patients with Budd‐Chiari syndrome or portal vein thrombosis

  2013cited by this paper
• Hydatid Cyst of Liver Complicated with Budd-Chiari Syndrome and Portal Vein Thrombosis

  2013cited by this paper
• Prevalence of inherited antithrombin, protein C, and protein S deficiencies in portal vein system thrombosis and Budd‐Chiari syndrome: A systematic review and meta‐analysis of observational studies

  2013cited by this paper
• Percutaneous recanalization for Budd-Chiari syndrome: an 11-year retrospective study on patency and survival in 177 Chinese patients from a single center.

  2013cited by this paper
• Familial Budd-Chiari Syndrome in China: A Systematic Review of the Literature

  2013cited by this paper
• Clinical features and etiology of Budd–Chiari syndrome in Chinese patients: A single‐center study

  2013cited by this paper
• Cardiac surgery: a rare and often overlooked cause of Budd–Chiari syndrome

  2013cited by this paper
• Risk of venous thromboembolism associated with single and combined effects of Factor V Leiden, Prothrombin 20210A and Methylenetethraydrofolate reductase C677T: a meta-analysis involving over 11,000 cases and 21,000 controls

  2013cited by this paper
• Large Clones With PNH-Type Phenotype are Not Common in Patients Presenting With Intra-Abdominal Thrombosis—A Prospective Study

  2013cited by this paper
• Another piece of the myeloproliferative neoplasms puzzle.

  2013cited by this paper
• The pathogenesis of the antiphospholipid syndrome.

  2013cited by this paper
• Somatic CALR mutations in myeloproliferative neoplasms with nonmutated JAK2.

  2013cited by this paper
• Antiphospholipid antibodies and the risk of recurrence after a first episode of venous thromboembolism: a systematic review.

  2013cited by this paper
• Good long‐term outcome of Budd‐Chiari syndrome with a step‐wise management

  2013cited by this paper
• Recurrent acute Budd–Chiari syndrome after right hepatectomy: US color-Doppler vascular pattern and left hepatic vein stenting for treatment

  2013cited by this paper
• Thrombotic risk factors in Chinese Budd-Chiari syndrome patients

  2013cited by this paper
• The frequency of factor V Leiden and prothrombin G20210A mutations in Slovak and Roma (Gypsy) ethnic group of Eastern Slovakia

  2012cited by this paper
• Prevalence of the JAK2V617F mutation in Chinese patients with Budd‐Chiari syndrome and portal vein thrombosis: A prospective study

  2012cited by this paper
• Paroxysmal nocturnal hemoglobinuria

  2012cited by this paper
• Clinical features and prognostic factors of Asian patients with paroxysmal nocturnal hemoglobinuria: results from a single center in China

  2012cited by this paper
• Myeloproliferative neoplasms in Budd-Chiari syndrome and portal vein thrombosis: a meta-analysis.

  2012cited by this paper
• Correlation of MTHFR C677T gene polymorphism plasma and Hcy levels in young patients with hepatic vein obstruction

  2012cited by this paper
• The JAK2 V617F somatic mutation, mortality and cancer risk in the general population

  2011cited by this paper
• Meta‐analysis: the significance of screening for JAK2V617F mutation in Budd–Chiari syndrome and portal venous system thrombosis

  2011cited by this paper
• Hepatic veins as a site of clot formation following liver resection.

  2011cited by this paper
• Endovascular treatment of Budd-Chiari syndrome.

  2011cited by this paper
• Vascular disorders of the liver: recommendations from the Italian Association for the Study of the Liver (AISF) ad hoc committee.

  2011cited by this paper
• Budd-Chiari syndrome secondary to hepatocellular carcinoma.

  2011cited by this paper
• Hyperhomocysteinemia and the methylene tetrahydrofolate reductase C677T mutation in splanchnic vein thrombosis

  2011cited by this paper
• Thrombocytopenia and acute Budd-Chiari syndrome after liver transplantation: heparin-induced thrombocytopenia.

  2011cited by this paper
• Epidemiological investigation of 1148 patients with Budd-Chiari syndrome

  2011cited by this paper
• Applicability of Different Endovascular Methods for Treatment of Refractory Budd–Chiari Syndrome

  2011cited by this paper
• Familial risks of unusual forms of venous thrombosis: a nationwide epidemiological study in Sweden

  2011influential reference
• Proteomic analysis reveals that apolipoprotein A1 levels are decreased in patients with Budd-Chiari syndrome.

  2011cited by this paper
• The JAK2 46/1 haplotype in Budd-Chiari syndrome and portal vein thrombosis.

  2011cited by this paper
• Antiphospholipid syndrome.

  2010cited by this paper
• Remnant Torsion Causing Budd-Chiari Syndrome After Right Hepatectomy

  2010cited by this paper
• Vascular disorders of the liver

  2009cited by this paper
• The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes.

  2009cited by this paper
• Thrombophilia testing in patients with venous thromboembolism. Findings from the RIETE registry.

  2009cited by this paper
• A germline JAK2 SNP is associated with predisposition to the development of JAK2V617F-positive myeloproliferative neoplasms

  2009cited by this paper
• Advances in Understanding and Management of Myeloproliferative Neoplasms

  2009cited by this paper
• A common JAK2 haplotype confers susceptibility to myeloproliferative neoplasms

  2009cited by this paper
• Predictive value of factor V Leiden and prothrombin G20210A in adults with venous thromboembolism and in family members of those with a mutation: a systematic review.

  2009cited by this paper
• Etiology, management, and outcome of the Budd-Chiari syndrome.

  2009cited by this paper
• Primary Budd-Chiari syndrome.

  2009cited by this paper
• Paroxysmal nocturnal hemoglobinuria in Budd-Chiari syndrome: findings from a cohort study.

  2009influential reference
• JAK2 haplotype is a major risk factor for the development of myeloproliferative neoplasms

  2009cited by this paper
• Budd‐Chiari syndrome in Sweden: epidemiology, clinical characteristics and survival – an 18‐year experience

  2009cited by this paper
• TIPS for Budd-Chiari syndrome: long-term results and prognostics factors in 124 patients.

  2008influential reference
• Vascular Diseases of the Liver

  2008cited by this paper
• The impact of JAK2 and MPL mutations on diagnosis and prognosis of splanchnic vein thrombosis: a report on 241 cases.

  2008cited by this paper
• Incidence and risk patterns of venous thromboembolism in pregnancy and puerperium--a register-based case-control study.

  2008cited by this paper
• Laboratory testing and identification of antiphospholipid antibodies and the antiphospholipid syndrome: a potpourri of problems, a compilation of possible solutions.

  2008cited by this paper
• Budd–Chiari syndrome and veno-occlusive disease/sinusoidal obstruction syndrome

  2008cited by this paper
• Maternal smoking, obesity, and risk of venous thromboembolism during pregnancy and the puerperium: a population-based nested case-control study.

  2007cited by this paper
• Changing profile of Budd Chiari syndrome in India.

  2007influential reference
• JAK2(V617F): Prevalence in a large Chinese hospital population.

  2007cited by this paper
• The risk of recurrent venous thromboembolism among heterozygous carriers of factor V Leiden or prothrombin G20210A mutation. A systematic review of prospective studies.

  2007cited by this paper

• Budd Chiari Syndrome: Presentation, Management, and Prognosis.

  2025cites this paper
• Interventional Radiology Management of Budd-Chiari Syndrome: Current Concepts.

  2025cites this paper
• Acute liver failure as initial presentation in a Chinese patient with Budd-Chiari syndrome due to protein C deficiency: A case report and literature review

  2024cites this paper
• Point-of-care ultrasound in the diagnosis and treatment of Budd-Chiari syndrome: A rare case report and literature review

  2024cites this paper
• Hepatic vein thrombosis and PVT: A personal view on the contemporary development of ideas

  2024cites this paper
• Survival and clinical success of endovascular intervention in patients with Budd-Chiari syndrome: A systematic review

  2023cites this paper
• Management of splanchnic vein thrombosis

  2023cites this paper
• Development of a prognostic scoring system for hepatic vena cava Budd-Chiari syndrome with hepatocellular carcinoma.

  2023cites this paper
• Budd-Chiari syndrome mimicking autoimmune hepatitis

  2023cites this paper
• Prothrombotic states in portal vein thrombosis and Budd-Chiari syndrome in India: A systematic review and meta-analysis

  2023cites this paper
• Reversion of liver cirrhosis after endovascular treatment in Chinese patients with Budd–Chiari syndrome

  2023cites this paper
• TIPS with a Twist - The Real Life Management of a Case of Budd-Chiari-related Acute Liver and Subsequent Multiple Organ Failure.

  2023cites this paper
• Direct oral anticoagulants for the treatment of splanchnic vein thrombosis: A state of art

  2023cites this paper
• Timing of Treatment for Budd-Chiari Syndrome: Still an Open Issue.

  2022cites this paper
• Establishment and validation of a prediction model for the first recurrence of Budd–Chiari syndrome after endovascular treatment: a large sample size, single-center retrospective study

  2022cites this paper
• Percutaneous transluminal angioplasty for symptomatic hepatic vein-type Budd-Chiari syndrome: feasibility and long-term outcomes

  2022cites this paper
• Budd–Chiari Syndrome Management: Controversies and Open Issues

  2022cites this paper
• Diagnosis and classification of vascular liver disorders

  2022cites this paper
• Acute liver failure in Budd–Chiari syndrome and a model to predict mortality

  2021cites this paper
• Síndrome de Budd-Chiari por obstrução da via de saída da veia hepática por membrana: tratamento percutâneo por angioplastia com balão

  2021cites this paper
• A rare case of constrictive pericarditis with Budd–Chiari syndrome due to right atrial thrombosis

  2021cites this paper
• Budd-Chiari syndrome: consensus guidance of the Asian Pacific Association for the study of the liver (APASL)

  2021cites this paper
• Budd-Chiari Syndrome: Hepatic Venous Outflow Tract Obstruction

  2021cites this paper
• Differential cytokine profiles in patients with viral and non-viral related liver cirrhosis

  2021cites this paper
• Budd-Chiari syndrome due to hepatic venous web outflow obstruction: percutaneous treatment with balloon angioplasty

  2021cites this paper
• ACG Clinical Guideline: Disorders of the Hepatic and Mesenteric Circulation.

  2020cites this paper
• Agreed diagnostic criteria needed for Budd-Chiari syndrome.

  2020cites this paper
• A Comparison of Splenic Pathologic Change and Immune Function in HBV-Related Portal Hypertension and Chinese Budd-Chiari Syndrome Patients with Hypersplenism

  2020cites this paper
• Budd-Chiari Syndrome

  2020influential citation
• Epidemiological Characteristics and Etiology of Budd-Chiari Syndrome in Upper Egypt

  2020cites this paper
• An Update on the Management of Budd–Chiari Syndrome

  2020cites this paper
• Budd-Chiari Syndrome: An Uncommon Cause of Chronic Liver Disease that Cannot Be Missed.

  2020cites this paper
• Sequential interventional therapy for Budd-Chiari syndrome associated with fresh inferior vena cava thrombosis.

  2020cites this paper
• Budd–Chiari Syndrome in Children

  2019cites this paper
• Epidemiology of Budd-Chiari syndrome: A systematic review and meta-analysis.

  2019cites this paper
• TIPSS for variceal bleeding in patients with idiopathic non‐cirrhotic portal hypertension: comparison with patients who have cirrhosis

  2019cites this paper
• Review article: a multidisciplinary approach to the diagnosis and management of Budd‐Chiari syndrome

  2019influential citation
• Current knowledge in pathophysiology and management of Budd-Chiari syndrome and non-cirrhotic non-tumoral splanchnic vein thrombosis.

  2019cites this paper
• Hepatic Venous Outflow Syndromes and Splanchnic Venous Thrombosis

  2019cites this paper
• Long‐term outcomes of individualized treatment strategy in treatment of type I Budd‐Chiari syndrome in 456 patients

  2019cites this paper
• Budd‐Chiari syndrome in the West and the East: Same syndrome, different diseases

  2019cites this paper
• Interventional Treatment Strategy for Primary Budd–Chiari Syndrome with Both Inferior Vena Cava and Hepatic Vein Involvement: Patients from Two Centers in China

  2019cites this paper
• Budd-Chiari syndrome hemodynamic: Clinical setting more complicated than computational model.

  2019cites this paper
• Considerations for a computer model for the hepatic circulation under chronic Budd-Chiari syndrome conditions.

  2019cites this paper
• Prevalence of prothrombotic factors in patients with Budd–Chiari syndrome or non‐cirrhotic nonmalignant portal vein thrombosis: A hospital‐based observational study

  2019cites this paper
• Obstructed membranous transformation of the inferior vena cava in patients with hepatic vein-type Budd-Chiari syndrome: A case series.

  2019cites this paper
• Epidemiology of Budd–Chiari Syndrome

  2019cites this paper
• Controversies in the Management of Budd–Chiari Syndrome

  2019cites this paper
• Pathology of Budd–Chiari Syndrome and Hepatic Vein Obstruction

  2019cites this paper
• Budd–Chiari Syndrome and Paroxysmal Nocturnal Hemoglobinuria

  2019cites this paper
• Anticoagulation for Budd–Chiari Syndrome

  2019cites this paper
• DIAGNOSTIC VALUE OF JAK2 V617F MUTATIONAL SCREENING IN PATIENTS WITH BUDD-CHIARI SYNDROME

  2019cites this paper
• Síndrome de Budd Chiari de aparición en el puerperio: Reporte de caso y revisión de la literatura

  2019cites this paper
• Syndrome de Budd-Chiari : diagnostic et traitement

  2019cites this paper
• Diagnosis of Budd–Chiari syndrome

  2018cites this paper
• The epidemiology of Budd-Chiari syndrome in France.

  2018cites this paper
• Budd–Chiari syndrome/hepatic venous outflow tract obstruction

  2018cites this paper
• Image-guided treatment of Budd-Chiari syndrome: a giant leap from the past, a small step towards the future

  2018cites this paper
• Prevalence of CALR mutations in splanchnic vein thrombosis: A systematic review and meta-analysis.

  2018cites this paper
• Angioplasty for Budd-Chiari Syndrome in a Child with 26-Year Follow-up.

  2018cites this paper
• Treatment of Budd-Chiari Syndrome Complicated by Inferior Vena Cava Thrombosis: Individualised or Non-reproducible Strategy?

  2018cites this paper
• Response to "Re: Treatment of Budd-Chiari Syndrome Complicated by Inferior Vena Cava Thrombosis: Individualised or Non-reproducible Strategy?"

  2018cites this paper
• Detecting CALR Mutations in Splanchnic Vein Thrombosis: Who and How?

  2018cites this paper
• Validation of prognostic indices in Egyptian Budd-Chiari syndrome patients: A single-center study

  2017cites this paper
• Showing one’s true CALRs: spleen size and platelet count help refine the molecular diagnostic pathway for patients with splanchnic vein thrombosis

  2017cites this paper
• Timing of transjugular intrahepatic portosystemic shunt for Budd-Chiari syndrome: An Italian hepatologist’s perspective

  2017cites this paper
• Liver cirrhosis caused by chronic Budd–Chiari syndrome

  2017cites this paper
• Budd Chiari syndrome presenting with hepatic transient mosaic enhancement pattern and treated with early transjugular intrahepatic portosystemic shunt

  2017cites this paper